Influences of trimethoprim-sulphamethoxazole and chloramphenicol on immunoglobulin and antibody response in typhoid fever.
D000284:Administration, Oral; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D002701:Chloramphenicol / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006382:Hemadsorption; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis*; D008297:Male; D012485:Salmonella typhi / Q000276:immunology; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000627:therapeutic use*; D013624:Taiwan; D014295:Trimethoprim / Q000008:administration & dosage / Q000627:therapeutic use*; D014435:Typhoid Fever / Q000188:drug therapy / Q000276:immunology*
D000906:Antibodies; D004338:Drug Combinations; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D002701:Chloramphenicol; D014295:Trimethoprim; D013420:Sulfamethoxazole